Cloudbreak Pharma Inc. (HKG:2592)
Hong Kong · Delayed Price · Currency is HKD 1.170
+0.020 (1.74%)
Jul 31, 2026, 4:08 PM HKT
Cloudbreak Pharma Market Cap
Cloudbreak Pharma has a market cap or net worth of 988.14 million as of July 31, 2026. Its market cap has decreased by -78.85% in one year.
Market Cap
988.14M
Enterprise Value
539.90M
Revenue
1.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.17
ChartMarket Cap Chart
Since July 3, 2025, Cloudbreak Pharma's market cap has decreased from 5.20B to 988.14M, a decrease of -81.00%. That is a compound annual growth rate of -78.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 988.14M | -77.35% |
| Dec 31, 2025 | 4.36B | -16.13% |
| Jul 3, 2025 | 5.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 1.49B |
| Zhaoke Ophthalmology | 1.36B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.30B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.29B |
| Beijing Biostar Pharmaceuticals | 1.29B |
| CANbridge Pharmaceuticals | 1.18B |
| Sunho Biologics | 970.43M |
| Cutia Therapeutics | 872.08M |